Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
J Histochem Cytochem ; 65(3): 173-184, 2017 03.
Artigo em Inglês | MEDLINE | ID: mdl-28056182

RESUMO

In response to toxic stressors, cancer cells defend themselves by mobilizing one or more epidermal growth factor receptor (EGFR) cascades that employ xeroderma pigmentosum-A (XPA) to repair damaged genes. Recent experiments discovered that neurons within the auditory nerve exhibit basal levels of EGFR+XPA co-expression. This finding implied that auditory neurons in particular or neurons in general have the capacity to mobilize an EGFR+XPA defense. Therefore, the current study tested the hypothesis that noise stress would alter the expression pattern of EGFR/XPA within the auditory nerve. Design-based stereology was used to quantify the proportion of neurons that expressed EGFR, XPA, and EGFR+XPA with and without noise stress. The results revealed an intricate neuronal response that is suggestive of alterations to both co-expression and individual expression of EGFR and XPA. In both the apical and middle cochlear coils, the noise stress depleted EGFR+XPA expression. Furthermore, there was a reduction in the proportion of neurons that expressed XPA-alone in the middle coils. However, the noise stress caused a significant increase in the proportion of neurons that expressed EGFR-alone in the middle coils. The basal cochlear coils failed to mobilize a significant response to the noise stress. These results suggest that EGFR and XPA might be part of the molecular defense repertoire of the auditory nerve.


Assuntos
Nervo Coclear/fisiologia , Nervo Coclear/ultraestrutura , Receptores ErbB/análise , Ruído , Estresse Fisiológico , Proteína de Xeroderma Pigmentoso Grupo A/análise , Animais , Nervo Coclear/química , Receptores ErbB/metabolismo , Imuno-Histoquímica/métodos , Masculino , Neurônios/química , Neurônios/metabolismo , Neurônios/ultraestrutura , Ratos Long-Evans , Gânglio Espiral da Cóclea/química , Gânglio Espiral da Cóclea/fisiologia , Gânglio Espiral da Cóclea/ultraestrutura , Proteína de Xeroderma Pigmentoso Grupo A/metabolismo
2.
Mol Carcinog ; 56(2): 447-463, 2017 02.
Artigo em Inglês | MEDLINE | ID: mdl-27253463

RESUMO

The enhancer of zeste homolog 2 (EZH2) is involved in a number of fundamental pathological processes of cancer. However, its role in DNA repair pathway is still unclear. Here, we have identified XPA as a novel target gene of EZH2 via a DNA repair pathway PCR array. XPA plays a pivot role in nucleotide excision repair (NER). The expression of XPA was significantly increased by EZH2 specific inhibitor GSK126 or lentiviral shEZH2 in nasopharyngeal carcinoma (NPC) CNE and 8F cell lines. Chromatin immunoprecipitation assay demonstrated that EZH2 catalyzes H3K27 trimethylation at the XPA promoters. Furthermore, we validated the negative correlation of EZH2 and XPA in a NPC tissue microarray by immunohistochemistry staining. We also found that high expression of EZH2 was positively correlated with advanced T, N, and AJCC stage of NPC; and low expression of XPA was positively correlated with advanced T and N stage. In NPC cell lines, increased XPA expression by EZH2 inhibition resulted in a more rapid removal of UVC induced 6-4PP- and CPD-DNA adducts, as well as enhanced efficiency of DNA repair after UVC irradiation as detected by the Comet assay and immunofluorescence staining of γH2Ax. Consistently, increased cell clonogenic survival, decreased apoptosis, and necrosis after UVC irradiation, and increased resistance to DNA damaging agent cisplatin was also observed in EZH2 inhibited cells. These results illustrate that EZH2 may promote carcinogenesis and cancer development of NPC by transcriptional repression of XPA gene and inactivation of NER pathway. © 2016 Wiley Periodicals, Inc.


Assuntos
Carcinoma/genética , Carcinoma/patologia , Reparo do DNA , Proteína Potenciadora do Homólogo 2 de Zeste/metabolismo , Regulação Neoplásica da Expressão Gênica , Neoplasias Nasofaríngeas/genética , Neoplasias Nasofaríngeas/patologia , Nasofaringe/patologia , Proteína de Xeroderma Pigmentoso Grupo A/genética , Antineoplásicos/farmacologia , Carcinoma/tratamento farmacológico , Carcinoma/metabolismo , Linhagem Celular Tumoral , Cisplatino/farmacologia , Regulação para Baixo , Proteína Potenciadora do Homólogo 2 de Zeste/análise , Proteína Potenciadora do Homólogo 2 de Zeste/genética , Código das Histonas , Humanos , Carcinoma Nasofaríngeo , Neoplasias Nasofaríngeas/tratamento farmacológico , Neoplasias Nasofaríngeas/metabolismo , Nasofaringe/efeitos dos fármacos , Nasofaringe/metabolismo , Regiões Promotoras Genéticas , Proteína de Xeroderma Pigmentoso Grupo A/análise , Proteína de Xeroderma Pigmentoso Grupo A/metabolismo
3.
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi ; 28(11): 1182-4, 2012 Nov.
Artigo em Chinês | MEDLINE | ID: mdl-23127410

RESUMO

AIM: To investigate the influence on platinum-based chemotherapy sensitivity by silencing xeroderma pigmentosum group A (XPA) gene expression in non-small cell lung cancer (NSCLC) drug resistance cell lines (A549/DDP). METHODS: We detected the expression of XPA in lung normal and tumor tissues by immunohistochemistry, quantitative real-time PCR (qPCR) and Western blotting. We silenced XPA expression in A549/DDP cells by XPA-shRNA transfection, and detected the expression of XPA by qPCR and Western blotting. The cell sensitivity to cisplatin and the apoptosis of A549/DDP cells transfected with XPA-shRNA were determined by MTT assay. RESULTS: The expression of XPA was higher in NSCLC tissues than that in normal lung tissues. Silencing XPA gene increased the apoptosis and sensitivity of A549/DDP cells to cisplatin. CONCLUSION: Silencing XPA gene can partly reverse the cisplatin resistance in human cisplatin-resistant NSCLC cell line A549/DDP.


Assuntos
Neoplasias Pulmonares/tratamento farmacológico , Proteína de Xeroderma Pigmentoso Grupo A/fisiologia , Antineoplásicos/farmacologia , Apoptose/efeitos dos fármacos , Linhagem Celular Tumoral , Cisplatino/farmacologia , Resistencia a Medicamentos Antineoplásicos , Humanos , Neoplasias Pulmonares/química , Neoplasias Pulmonares/patologia , Proteína de Xeroderma Pigmentoso Grupo A/análise , Proteína de Xeroderma Pigmentoso Grupo A/genética
4.
Cell Biol Int ; 36(8): 713-20, 2012 Aug 01.
Artigo em Inglês | MEDLINE | ID: mdl-22578086

RESUMO

RPA (replication protein A), the eukaryotic ssDNA (single-stranded DNA)-binding protein, participates in most cellular processes in response to genotoxic insults, such as NER (nucleotide excision repair), DNA, DSB (double-strand break) repair and activation of cell cycle checkpoint signalling. RPA interacts with XPA (xeroderma pigmentosum A) and functions in early stage of NER. We have shown that in cells the RPA-XPA complex disassociated upon exposure of cells to high dose of UV irradiation. The dissociation required replication stress and was partially attributed to tRPA hyperphosphorylation. Treatment of cells with CPT (camptothecin) and HU (hydroxyurea), which cause DSB DNA damage and replication fork collapse respectively and also leads to the disruption of RPA-XPA complex. Purified RPA and XPA were unable to form complex in vitro in the presence of ssDNA. We propose that the competition-based RPA switch among different DNA metabolic pathways regulates the dissociation of RPA with XPA in cells after DNA damage. The biological significances of RPA-XPA complex disruption in relation with checkpoint activation, DSB repair and RPA hyperphosphorylation are discussed.


Assuntos
Dano ao DNA/efeitos dos fármacos , Replicação do DNA , DNA/metabolismo , Proteína de Replicação A/metabolismo , Proteína de Xeroderma Pigmentoso Grupo A/metabolismo , Camptotecina/farmacologia , Pontos de Checagem do Ciclo Celular , Linhagem Celular Tumoral , Dano ao DNA/efeitos da radiação , Reparo do DNA , DNA de Cadeia Simples/metabolismo , Regulação para Baixo , Humanos , Hidroxiureia/farmacologia , Fosforilação/efeitos dos fármacos , Ligação Proteica , Proteína de Replicação A/análise , Raios Ultravioleta , Proteína de Xeroderma Pigmentoso Grupo A/análise
5.
Nucleic Acids Res ; 39(12): 5057-66, 2011 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-21398635

RESUMO

The DNA of patients taking immunosuppressive and anti-inflammatory thiopurines contains 6-thioguanine (6-TG) and their skin is hypersensitive to ultraviolet A (UVA) radiation. DNA 6-TG absorbs UVA and generates reactive oxygen species that damage DNA and proteins. Here, we show that the DNA damage includes covalent DNA-protein crosslinks. An oligonucleotide containing a single 6-TG is photochemically crosslinked to cysteine-containing oligopeptides by low doses of UVA. Crosslinking is significantly more efficient if guanine sulphonate (G(SO3))--an oxidized 6-TG and a previously identified UVA photoproduct--replaces 6-TG, suggesting that G(SO3) is an important reaction intermediate. Crosslinking occurs via oligopeptide sulphydryl and free amino groups. The oligonucleotide-oligopeptide adducts are heat stable but are partially reversed by reducing treatments. UVA irradiation of human cells containing DNA 6-TG induces extensive heat- and reducing agent-resistant covalent DNA-protein crosslinks and diminishes the recovery of some DNA repair and replication proteins from nuclear extracts. DNA-protein crosslinked material has an altered buoyant density and can be purified by banding in cesium chloride (CsCl) gradients. PCNA, the MSH2 mismatch repair protein and the XPA nucleotide excision repair (NER) factor are among the proteins detectable in the DNA-crosslinked material. These findings suggest that the 6-TG/UVA combination might compromise DNA repair by sequestering essential proteins.


Assuntos
Dano ao DNA , Proteínas de Ligação a DNA/química , DNA/química , Proteínas Nucleares/química , Tioguanina/química , Raios Ultravioleta , DNA/efeitos da radiação , Reparo do DNA , Replicação do DNA , Proteínas de Ligação a DNA/análise , Eletroforese em Gel Bidimensional , Humanos , Proteína 2 Homóloga a MutS/análise , Proteínas Nucleares/análise , Oligopeptídeos/química , Processos Fotoquímicos , Antígeno Nuclear de Célula em Proliferação/análise , Células Tumorais Cultivadas , Proteína de Xeroderma Pigmentoso Grupo A/análise
6.
Nucleic Acids Res ; 38(22): 8083-94, 2010 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-20693538

RESUMO

The interaction of xeroderma pigmentosum group A protein (XPA) and replication protein A (RPA) with damaged DNA in nucleotide excision repair (NER) was studied using model dsDNA and bubble-DNA structure with 5-{3-[6-(carboxyamido-fluoresceinyl)amidocapromoyl]allyl}-dUMP lesions in one strand and containing photoreactive 5-iodo-dUMP residues in defined positions. Interactions of XPA and RPA with damaged and undamaged DNA strands were investigated by DNA-protein photocrosslinking and gel shift analysis. XPA showed two maximums of crosslinking intensities located on the 5'-side from a lesion. RPA mainly localized on undamaged strand of damaged DNA duplex and damaged bubble-DNA structure. These results presented for the first time the direct evidence for the localization of XPA in the 5'-side of the lesion and suggested the key role of XPA orientation in conjunction with RPA binding to undamaged strand for the positioning of the NER preincision complex. The findings supported the mechanism of loading of the heterodimer consisting of excision repair cross-complementing group 1 and xeroderma pigmentosum group F proteins by XPA on the 5'-side from the lesion before damaged strand incision. Importantly, the proper orientation of XPA and RPA in the stage of preincision was achieved in the absence of TFIIH and XPG.


Assuntos
Dano ao DNA , Reparo do DNA , Proteína de Replicação A/metabolismo , Proteína de Xeroderma Pigmentoso Grupo A/metabolismo , DNA/química , DNA/metabolismo , Pegada de DNA , Desoxirribonucleases/metabolismo , Proteína de Replicação A/análise , Proteína de Xeroderma Pigmentoso Grupo A/análise
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA